Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase 4, 8-week, Double-blind, Randomized, Placebo-controlled Study Evaluating the Efficacy of Duloxetine 60 mg Once Daily in Outpatients with Major Depressive Disorder and Associated Painful Physical Symptoms
Duloxetine hydrochloride
F1J-US-HMGR
NCT01000805
Major Depressive Disorder
Phase 4
 
The annotated case report form is not available. A blank case report form will be provided.
May 2015

Powered by ideaPoint, Inc.